Ignite Creation Date:
2024-05-06 @ 12:42 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01634893
Status:
COMPLETED
Last Update Posted:
2016-03-25
First Post:
2012-07-03
Brief Title:
Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
The University of Texas Health Science Center at San Antonio
Organization Data
Organization:
The University of Texas Health Science Center at San Antonio
Class:
OTHER
Study ID:
CTRC 11-71
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None